ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

Google Scholar citation report
Citations : 5129

Clinical Schizophrenia & Related Psychoses received 5129 citations as per Google Scholar report

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In



Putative/New Antipsychotics
Author(s): Peter F. Buckley

The U.S. Food and Drug Administration (FDA) has approved lurasidone for use in adolescents (aged 13–17 years) with schizophrenia. The FDA’s extension of lurasidone to the adolescent population was based on the positive efficacy results from a six-week, placebo-controlled trial of 40 or 80 mg/day. Both doses of lurasidone were effective.